Nasdaq · Materials
BALCHEM CORP (BCPC)
As-reported financials and recent SEC filings for BALCHEM CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.04B
Net income
$154.8M
Net margin
14.9%
Diluted EPS
$4.75
ROE
12.3%
P/E (TTM)
35.2×
Market cap
$5.50B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.04B | $953.7M | $922.4M | $942.4M | $799.0M |
| Gross profit | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M |
| Operating income | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M |
| Net income | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M |
| Diluted EPS | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-22
View on EDGAR →11-K2026-06-18
View on EDGAR →10-Q2026-04-30
View on EDGAR →8-K2026-04-30
View on EDGAR →SCHEDULE 13G2026-04-29
View on EDGAR →SCHEDULE 13G2026-04-28
View on EDGAR →DEFA14A2026-04-27
View on EDGAR →DEF 14A2026-04-27
View on EDGAR →Go deeper on BCPC
Search BALCHEM CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.